4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001415889-24-022941
Director sold 47,689 shares at an average $4.02 ($191,655)
- Director acquired 47,689 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Erck Stanley C Director | 2024-09-03 | Option exercise 10b5-1 | +17,922 | $0.04 | $717 | 287,040 | D |
| Erck Stanley C Director | 2024-09-03 | Sale 10b5-1 | −17,922 | $4.10 | $73,480 | 269,118 | D |
| Erck Stanley C Director | 2024-09-04 | Option exercise 10b5-1 | +29,767 | $0.04 | $1,191 | 298,885 | D |
| Erck Stanley C Director | 2024-09-04 | Sale 10b5-1 | −29,767 | $3.97 | $118,175 | 269,118 | D |
| Derivatives | |||||||
| Erck Stanley C Director | 2024-09-03 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −17,922 | 125,145 | D | ||
| Erck Stanley C Director | 2024-09-04 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −29,767 | 95,378 | D | ||
| Open-market sales · 47,689 sh · avg $4.02 · $191,655 | |||||||
Loading xslF345X05/form4-09052024_090936.xml…